Clinical Trial Update: Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a melanoma vaccine with or without sargramostim in patients with stage IIB through IV melanoma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melanoma vaccine
• sargramostim (sargramostim)

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED